Dysfunction of antigen processing and presentation by dendritic cells in cancer.
Antigen processing and presentation
Cancer
Journal
Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
06
09
2017
revised:
31
01
2018
accepted:
29
03
2018
pubmed:
10
4
2018
medline:
23
1
2020
entrez:
10
4
2018
Statut:
ppublish
Résumé
The ability to mount an effective anti-tumor immune response requires coordinate control of CD4 T cell and CD8 T cell function by antigen presenting cells (APCs). Unfortunately, tumors create an immunosuppressive microenvironment that helps protect tumor cells from immune recognition. In many cases this defect can be traced back to a failure of APCs (most importantly dendritic cells (DCs)) to recognize, process, and present tumor antigens to T cells. In this review, we will summarize work addressing the role of different DC subsets in anti-tumor immunity and the various mechanisms used by tumor cells to suppress the ability of APCs to stimulate potent anti-tumor T cell responses.
Identifiants
pubmed: 29628265
pii: S0161-5890(18)30104-4
doi: 10.1016/j.molimm.2018.03.025
pmc: PMC6173666
mid: NIHMS957900
pii:
doi:
Substances chimiques
Antigens, Neoplasm
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
31-37Subventions
Organisme : Intramural NIH HHS
ID : Z01 BC009404-13
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 BC009404-14
Pays : United States
Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.
Références
Eur J Cancer. 2016 Nov;68:134-147
pubmed: 27755997
Cancer Cell. 2017 May 8;31(5):711-723.e4
pubmed: 28486109
Ann N Y Acad Sci. 2011 Jan;1217:60-76
pubmed: 21155836
Nat Rev Immunol. 2008 Jan;8(1):59-73
pubmed: 18097448
Mol Immunol. 2006 Jul;43(14):2151-60
pubmed: 16490253
Cancer Immunol Res. 2013 Dec;1(6):402-15
pubmed: 24778133
Future Oncol. 2013 Apr;9(4):469-72
pubmed: 23560368
New J Sci. 2014 Jan 5;2014:
pubmed: 24634791
Front Immunol. 2015 Nov 23;6:584
pubmed: 26635798
Immunity. 2007 Apr;26(4):519-31
pubmed: 17412618
Front Immunol. 2012 Sep 04;3:274
pubmed: 22969767
Blood. 2005 Mar 15;105(6):2465-72
pubmed: 15546948
J Exp Med. 2007 Jun 11;204(6):1441-51
pubmed: 17535975
J Exp Med. 2010 Apr 12;207(4):823-36
pubmed: 20351058
Blood. 1998 Oct 1;92(7):2252-9
pubmed: 9746762
J Immunol. 2009 Jun 15;182(12):7587-94
pubmed: 19494282
Nat Rev Cancer. 2012 Mar 22;12(4):265-77
pubmed: 22437871
J Exp Med. 2011 Sep 26;208(10):1989-2003
pubmed: 21930769
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
J Immunol. 1998 Sep 1;161(5):2099-105
pubmed: 9725200
Immunity. 2009 Nov 20;31(5):823-33
pubmed: 19913446
Front Immunol. 2013 Jun 10;4:138
pubmed: 23772226
Exp Hematol. 2009 Feb;37(2):184-194
pubmed: 19081173
J Clin Invest. 1998 Jun 15;101(12):2720-9
pubmed: 9637706
Int J Cancer. 2001 Jan 20;95(1):23-8
pubmed: 11241306
Immunogenetics. 2008 Aug;60(8):439-47
pubmed: 18545995
Nature. 2001 Apr 26;410(6832):1107-11
pubmed: 11323675
Cancer Res. 2013 Feb 1;73(3):1063-75
pubmed: 23345163
J Immunol. 2002 Apr 15;168(8):3771-6
pubmed: 11937528
Cancer Cell. 2016 Aug 8;30(2):324-336
pubmed: 27424807
Cancer Res. 2012 May 1;72(9):2162-71
pubmed: 22549946
Am J Hematol. 2007 Oct;82(10):924-8
pubmed: 17636477
Nat Med. 2010 Aug;16(8):880-6
pubmed: 20622859
Nat Rev Immunol. 2014 Aug;14(8):571-8
pubmed: 25033907
Semin Cancer Biol. 2007 Dec;17(6):413-21
pubmed: 17881247
Immunity. 1997 Mar;6(3):293-302
pubmed: 9075930
J Exp Med. 2011 Sep 26;208(10):2005-16
pubmed: 21930765
Nat Rev Immunol. 2015 Aug;15(8):471-85
pubmed: 26160613
J Exp Med. 2010 Jun 7;207(6):1273-81
pubmed: 20479115
J Clin Invest. 2007 Sep;117(9):2570-82
pubmed: 17710230
Cell Rep. 2015 Dec 29;13(12):2851-64
pubmed: 26711349
Curr Opin Immunol. 2015 Jun;34:22-7
pubmed: 25597442
Oncoimmunology. 2013 May 1;2(5):e23851
pubmed: 23762786
Trends Mol Med. 2008 Mar;14(3):109-19
pubmed: 18261959
Immunity. 2008 Sep 19;29(3):352-61
pubmed: 18799143
J Clin Invest. 2012 Feb;122(2):575-85
pubmed: 22251703
Blood. 1997 Sep 15;90(6):2390-7
pubmed: 9310490
J Mol Med (Berl). 2008 Feb;86(2):145-60
pubmed: 17876564
J Exp Med. 2005 Oct 3;202(7):919-29
pubmed: 16186184
Immunol Today. 1999 Feb;20(2):60-2
pubmed: 10098322
Clin Cancer Res. 2005 Dec 1;11(23):8288-94
pubmed: 16322287
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8981-6
pubmed: 15184678
Cancer Res. 2012 Dec 1;72(23):6130-41
pubmed: 23026134
FASEB J. 2004 Sep;18(12):1439-41
pubmed: 15247147
Cell. 1995 Jul 14;82(1):155-65
pubmed: 7606781
J Exp Med. 2004 Mar 15;199(6):815-24
pubmed: 15024047
Science. 2006 Jan 6;311(5757):83-7
pubmed: 16322423
J Exp Med. 2000 Nov 6;192(9):1213-22
pubmed: 11067871
J Immunol. 2000 Oct 1;165(7):3797-803
pubmed: 11034385
Nat Immunol. 2001 Jul;2(7):585-9
pubmed: 11429541
Am J Clin Pathol. 2005 Jul;124(1):37-48
pubmed: 15923172
Clin Cancer Res. 2003 Feb;9(2):606-12
pubmed: 12576425
Science. 2008 Nov 14;322(5904):1097-100
pubmed: 19008445
Hum Immunol. 2000 Nov;61(11):1113-7
pubmed: 11137215
Cell. 2016 Mar 10;164(6):1233-1247
pubmed: 26967289
Immunity. 2013 Apr 18;38(4):729-41
pubmed: 23562161
Annu Rev Immunol. 2005;23:975-1028
pubmed: 15771591
Cancer Cell. 2014 Nov 10;26(5):638-52
pubmed: 25446897
J Exp Med. 2007 May 14;204(5):1037-47
pubmed: 17438063
Cancer. 2007 Nov 1;110(9):1911-28
pubmed: 17849470
J Immunol. 2015 Feb 15;194(4):1434-45
pubmed: 25595783
Nat Med. 2005 Dec;11(12):1314-21
pubmed: 16288283
J Clin Invest. 2004 Jul;114(2):280-90
pubmed: 15254595
Curr Opin Immunol. 2017 Apr;45:43-51
pubmed: 28192720
Cell Rep. 2016 Feb 23;14(7):1774-1786
pubmed: 26876172
Cancer Immunol Immunother. 2010 Aug;59(8):1273-84
pubmed: 20419298
Immunity. 2005 Nov;23(5):491-502
pubmed: 16286017
Int J Cancer. 2016 Jan 15;138(2):271-80
pubmed: 25471439
Science. 2003 Apr 11;300(5617):339-42
pubmed: 12690202
Immunity. 1995 May;2(5):533-43
pubmed: 7749984
Clin Cancer Res. 1997 Apr;3(4):573-8
pubmed: 9815722
J Immunol. 2004 Aug 1;173(3):1826-33
pubmed: 15265914
Nat Immunol. 2003 Aug;4(8):733-9
pubmed: 12888794
Cancer Res. 2005 Apr 15;65(8):3437-46
pubmed: 15833879
Nat Rev Immunol. 2015 Apr;15(4):203-16
pubmed: 25720354
J Immunol. 2004 Sep 15;173(6):3844-54
pubmed: 15356132
Nat Commun. 2015 Jun 25;6:7458
pubmed: 26109379
J Exp Med. 2007 Jan 22;204(1):105-15
pubmed: 17200410
Eur J Immunol. 2010 Aug;40(8):2094-8
pubmed: 20853492
Adv Cancer Res. 2001;83:117-58
pubmed: 11665717
Cell. 2006 Jul 14;126(1):205-18
pubmed: 16839887
Immunol Today. 2000 Sep;21(9):455-64
pubmed: 10953098
J Immunol. 2014 Nov 1;193(9):4283-8
pubmed: 25326546
Cancer Cell. 2014 Dec 8;26(6):938
pubmed: 28898680
Immunity. 2009 Nov 20;31(5):787-98
pubmed: 19879162
Cancer Cell. 2014 Nov 10;26(5):623-37
pubmed: 25446896
Cancer Res. 2009 Apr 1;69(7):3086-94
pubmed: 19293186
Immunity. 2016 Apr 19;44(4):924-38
pubmed: 27096321
Eur J Immunol. 2009 Apr;39(4):931-8
pubmed: 19197943
Nat Immunol. 2007 Aug;8(8):825-34
pubmed: 17589510
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2435-40
pubmed: 9482903
Cancer Cell. 2016 Oct 10;30(4):651
pubmed: 27728809
Immunogenetics. 2010 Feb;62(2):109-16
pubmed: 20024540
Science. 2015 Apr 3;348(6230):62-8
pubmed: 25838374
Science. 2011 Apr 29;332(6029):600-3
pubmed: 21474713
Nature. 2015 Jul 9;523(7559):231-5
pubmed: 25970248
Immunol Rev. 2010 Mar;234(1):142-62
pubmed: 20193017
Front Immunol. 2015 Jul 17;6:363
pubmed: 26236315
J Exp Med. 1973 May 1;137(5):1142-62
pubmed: 4573839
Eur J Immunol. 2003 Apr;33(4):1052-62
pubmed: 12672071
J Immunol. 1991 May 15;146(10):3444-51
pubmed: 1827484
Immunity. 1997 Oct;7(4):445-50
pubmed: 9354465
Annu Rev Immunol. 2010;28:445-89
pubmed: 20192806
Annu Rev Immunol. 2001;19:47-64
pubmed: 11244030
J Immunol. 2005 Mar 1;174(5):2591-601
pubmed: 15728465
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7064-9
pubmed: 15103024